no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
An acellular pertussis vaccine in healthy adults: safety and immunogenicity
|
Rothstein, Edward P. |
|
1999 |
17 |
23-24 |
p. 2999-3006 8 p. |
article |
2 |
Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax
|
de Oliveira, Camila I. |
|
1999 |
17 |
23-24 |
p. 2959-2968 10 p. |
article |
3 |
Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization
|
Hu, Guo-Jun |
|
1999 |
17 |
23-24 |
p. 3160-3170 11 p. |
article |
4 |
Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens
|
Rogers, William O |
|
1999 |
17 |
23-24 |
p. 3136-3144 9 p. |
article |
5 |
Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A
|
Rao, Mangala |
|
1999 |
17 |
23-24 |
p. 2991-2998 8 p. |
article |
6 |
Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco
|
Tackaberry, E.S |
|
1999 |
17 |
23-24 |
p. 3020-3029 10 p. |
article |
7 |
Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA
|
Shen, F. |
|
1999 |
17 |
23-24 |
p. 3039-3049 11 p. |
article |
8 |
Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment
|
Werle, Bettina |
|
1999 |
17 |
23-24 |
p. 2983-2990 8 p. |
article |
9 |
Erratum
|
|
|
1999 |
17 |
23-24 |
p. 3179- 1 p. |
article |
10 |
Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants
|
Sheikh, N.A |
|
1999 |
17 |
23-24 |
p. 2974-2982 9 p. |
article |
11 |
Hepatitis B vaccination in infancy in The Gambia: protection
|
Viviani, S. |
|
1999 |
17 |
23-24 |
p. 2946-2950 5 p. |
article |
12 |
Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant
|
Saul, Allan |
|
1999 |
17 |
23-24 |
p. 3145-3159 15 p. |
article |
13 |
Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood
|
MacLennan, Jenny |
|
1999 |
17 |
23-24 |
p. 3086-3093 8 p. |
article |
14 |
Immunity obtained by gene-gun inoculation of a rotavirus DNA vaccine to the abdominal epidermis or anorectal epithelium
|
Chen, Shing C |
|
1999 |
17 |
23-24 |
p. 3171-3176 6 p. |
article |
15 |
Immunization of mice with peptomers covalently coupled to aluminum oxide nanoparticles
|
Frey, Andreas |
|
1999 |
17 |
23-24 |
p. 3007-3019 13 p. |
article |
16 |
Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori
|
Lee, Cynthia K |
|
1999 |
17 |
23-24 |
p. 3072-3082 11 p. |
article |
17 |
Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi®)
|
Kroon, Frank P. |
|
1999 |
17 |
23-24 |
p. 2941-2945 5 p. |
article |
18 |
Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines
|
Rice, Jason |
|
1999 |
17 |
23-24 |
p. 3030-3038 9 p. |
article |
19 |
Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate
|
Fukasawa, Lucila O. |
|
1999 |
17 |
23-24 |
p. 2951-2958 8 p. |
article |
20 |
Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response
|
Ramakrishna, C |
|
1999 |
17 |
23-24 |
p. 3102-3108 7 p. |
article |
21 |
Patent report
|
|
|
1999 |
17 |
23-24 |
p. 3178- 1 p. |
article |
22 |
Patent report
|
|
|
1999 |
17 |
23-24 |
p. 3177- 1 p. |
article |
23 |
Patent report
|
|
|
1999 |
17 |
23-24 |
p. 3177- 1 p. |
article |
24 |
Patent report
|
|
|
1999 |
17 |
23-24 |
p. 3177- 1 p. |
article |
25 |
Patent report
|
|
|
1999 |
17 |
23-24 |
p. 3177- 1 p. |
article |
26 |
Potency test of inactivated Newcastle disease vaccines by monoclonal antibody blocking ELISA
|
Horváth, E. |
|
1999 |
17 |
23-24 |
p. 2969-2973 5 p. |
article |
27 |
Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine
|
Shah, S. |
|
1999 |
17 |
23-24 |
p. 3116-3123 8 p. |
article |
28 |
Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines
|
Robin, Guy |
|
1999 |
17 |
23-24 |
p. 3109-3115 7 p. |
article |
29 |
Response to HBV vaccine in relation to anti-HCV and anti-HBc positivity: a study in intravenous drug addicts
|
Minniti, F |
|
1999 |
17 |
23-24 |
p. 3083-3085 3 p. |
article |
30 |
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
|
De Donato, S |
|
1999 |
17 |
23-24 |
p. 3094-3101 8 p. |
article |
31 |
Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys
|
Jones, Trevor R. |
|
1999 |
17 |
23-24 |
p. 3065-3071 7 p. |
article |
32 |
The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant
|
Enioutina, Elena Y. |
|
1999 |
17 |
23-24 |
p. 3050-3064 15 p. |
article |
33 |
Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy
|
Caley, Ian J |
|
1999 |
17 |
23-24 |
p. 3124-3135 12 p. |
article |